Search Results

We sat down with our newest faculty to find out a bit more about what they'll be working on at the Crick.

Researchers at the Crick have found that blocking a specific protein could increase tumour sensitivity to treatment with PARP inhibitors. Their work, published in Science, suggests combining treatments could lead to improved therapy for patients with inheritable breast cancers.

  During training as a clinical oncologist, Matt Fittall joined the Crick in 2016 as one of our clinical fellows. He tells us what motivates him, how he taught himself to code, and where he sees himself in five years’ time.